Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-13

Clinical Trial Update: MSC-EVs in Acute/ Acute-on-Chronic Liver Failure After Liver Transplantation [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial entry evaluating mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) for acute liver failure and acute-on-chronic liver fail…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) (mesenchymal stem cell-derived extracellular vesicles)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Liver Failure, Mesenchymal Stem Cell | Phase 1 | Status: NOT_YET_RECRUITING